<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1964795/" ref="ordinalpos=3718&amp;ncbi_uid=1104750&amp;link_uid=PMC1964795" image-link="/pmc/articles/PMC1964795/figure/F5/" class="imagepopup">Figure 5. Anti-apoptotic mechanisms of Akt.  From: INHIBITION OF MAPK AND STIMULATION OF AKT KINASE <span class="highlight" style="background-color:">SIGNALING</span> PATHWAYS: TWO APPROACHES WITH THERAPEUTIC POTENTIAL IN THE TREATMENT OF NEURODEGENERATIVE DISEASE. </a></div><br /><div class="p4l_captionBody">Akt has been described to inhibit apoptosis at multiple levels: signaling pathways, transcription factors, and, in the intrinsic pathway of PCD, at pre-mitochondrial, mitochondrial, and post-mitochondrial levels. Detailed mechanisms for some of these pathways are presented in the text. For more complete reviews, see (Datta et al., 1999; Brunet et al., 2001; Downward, 2004).</div></div>